Shrader; William Dvorak

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shrader; William Dvorak.The latest application filed is for "2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors".

Company Profile

0.10.12

Shrader; William Dvorak - Belmont CA
Shrader; William Dvorak - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Factor VIIa inhibitor Grant 9,181,280 - Dickman , et al. November 10, 2	2015-11-10
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors Grant 9,162,986 - Kolesnikov , et al. October 20, 2	2015-10-20
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine Derivatives As Factor Viia Inhibitors App 20140378453 - KOLESNIKOV; Aleksandr ; et al.	2014-12-25
Factor Viia Inhibitor App 20140221667 - DICKMAN; Daniel A. ; et al.	2014-08-07
2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors Grant 8,778,625 - Kolesnikov , et al. July 15, 2	2014-07-15
Factor VIIa inhibitor Grant 8,729,117 - Dickman , et al. May 20, 2	2014-05-20
Factor Viia Inhibitor App 20140080879 - Dickman; Daniel A. ; et al.	2014-03-20
2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors App 20130157298 - Kolesnikov; Aleksandr ; et al.	2013-06-20
Factor VIIa inhibitor Grant 8,415,328 - Dickman , et al. April 9, 2	2013-04-09
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors Grant 8,299,110 - Kolesnikov , et al. October 30, 2	2012-10-30
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine Derivatives As Factor Viia Inhibitors App 20110269806 - Kolesnikov; Aleksandr ; et al.	2011-11-03
Factor Viia Inhibitor App 20110207939 - Dickman; Daniel A. ; et al.	2011-08-25
2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors App 20090054432 - KOLESNIKOV; Aleksandr ; et al.	2009-02-26
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors Grant 7,479,502 - Kolesnikov , et al. January 20, 2	2009-01-20
Factor Viia Inhibitor App 20080275250 - Dickman; Daniel A. ; et al.	2008-11-06
2-(2-Hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors App 20060205942 - Kolesnikov; Aleksandr ; et al.	2006-09-14
2-[5-(5-Carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-YL]-succinic acid derivatives as factor viia inhibitors App 20050176797 - Hu, Huiyong ; et al.	2005-08-11
(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors Grant 6,867,200 - Allen , et al. March 15, 2	2005-03-15
2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors App 20030114457 - Hu, Huiyong ; et al.	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.